Motus GI

Motus GI

MOTS
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $52M

Market Cap: $638Founded: 2011HQ: Fort Lauderdale, United States

Overview

Motus GI is a medical device company with a mission to improve clinical outcomes and cost-efficiency in GI endoscopy through its innovative Pure-Vu® System. The company has achieved key regulatory milestones, including FDA clearance and CE Mark, and has transitioned to commercial operations, targeting the significant inpatient and emergent endoscopy market. Its strategy centers on direct engagement with early-adopter hospitals and endoscopy centers, leveraging compelling clinical data that demonstrates dramatic improvements in procedural visualization and success rates.

Gastroenterology

Technology Platform

The Pure-Vu® System is a single-use medical device that integrates with standard endoscopes to provide simultaneous high-flow irrigation and suction, actively cleansing the GI tract during endoscopy to improve visualization.

Funding History

5
Total raised:$52M
PIPE$5M
IPO$10M
Series C$12M
Series B$15M

Opportunities

The core opportunity lies in addressing the ~2 million annual inpatient/emergent GI procedures in the U.S.
where poor visualization leads to clinical and economic inefficiencies.
Successful penetration creates a beachhead for expansion into the massive outpatient endoscopy market.

Risk Factors

Key risks include slow commercial adoption in hospitals due to budget constraints or physician inertia, ongoing financial losses requiring dilutive capital raises, and potential future competition from larger medical device companies entering the space.

Competitive Landscape

Primary competition is the inefficient standard of care using the endoscope's own channels. The Pure-Vu System holds a first-mover advantage with specific FDA clearance and strong clinical data, but faces potential competition from other cleansing devices and must overcome entrenched clinical practices.

Company Timeline

2011Founded

Founded in Fort Lauderdale, United States

2016Series B

Series B: $15.0M

2017Series C

Series C: $12.0M

2018IPO

IPO — $10.0M